{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893977649280.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/j.1742-4658.2012.08500.x"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1742-4658.2012.08500.x"}},{"identifier":{"@type":"URI","@value":"https://febs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-4658.2012.08500.x"}}],"dc:title":[{"@value":"The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>This brief review will first consider HIV associated neurocognitive disorder followed by the current understanding of its neuropathogenesis. Against this background the role of the kynurenine pathway will be detailed. Evidence both direct and indirect will be discussed for involvement of the kynurenine pathway at each step in the neuropathogenesis of HIV associated neurocognitive disorder.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825893977649280","@type":"Researcher","foaf:name":[{"@value":"Apsara Kandanearatchi"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893977649281","@type":"Researcher","foaf:name":[{"@value":"Bruce J. Brew"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"1742464X"},{"@type":"EISSN","@value":"17424658"}],"prism:publicationName":[{"@value":"The FEBS Journal"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2012-03-27","prism:volume":"279","prism:number":"8","prism:startingPage":"1366","prism:endingPage":"1374"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1742-4658.2012.08500.x"},{"@id":"https://febs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1742-4658.2012.08500.x"}],"createdAt":"2012-01-20","modifiedAt":"2024-04-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282680084552832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure　― Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) ―"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1742-4658.2012.08500.x"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-16-0791_references_DOI_EcQdG3yFKmGFDMr9pHyqDkplZAd"}]}